Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC-01 (varenicline) for Dry Eye in Sjogren's Syndrome
NCT05700422Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- May 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varenicline + nicotine patch in dry eye disease (DED), sponsored by University of Pennsylvania. Primary endpoints: Mean Change in Cornea Staining at Day 28, Mean Change in Eye Dryness Score at Day 28 and 1 more. Started May 2023; status: completed.
02
Drugs
varenicline + nicotine patch
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05700422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05700422.